EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis

Mara-Luciana Floare iD, Scott P Allen iD

Neuroscience Insights · 2020-01 · 15

DOI: 10.1177/2633105520957302 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuroscience Insights, online erschienen am 17.09.2020. Verfasst von Mara-Luciana Floare und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sheffield Institute foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder for which there is no effective curative treatment available and minimal palliative care. Mutations in the gene encoding the TAR DNA-binding protein 43 (TDP-43) are a well-recognized genetic cause of ALS, and an imbalance in energy homeostasis correlates closely to disease susceptibility and progression. Considering previous research supporting a plethora of downstream cellular impairments originating in the histopathological signature of TDP-43, and the solid evidence around metabolic dysfunction in ALS, a causal association between TDP-43 pathology and metabolic dysfunction cannot be ruled out. Here we discuss how TDP-43 contributes on a molecular level to these impairments in energy homeostasis, and whether the protein’s pathological effects on cellular metabolism differ from those of other genetic risk factors associated with ALS such as superoxide dismutase 1 (SOD1), chromosome 9 open reading frame 72 (C9orf72) and fused in sarcoma (FUS).

Schlagwörter

Stichwörter der Autor:innen

ALSC9orf72FUSSOD1TDP-43fatty acids oxidationglycolysismetabolic defectsmetabolismmitochondria

Autor:innen und Institutionen

  • Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.

ORCID-Profile: Mara-Luciana Floare, Scott P Allen

Förderung

  • Sheffield Institute foundation

Zitieren

APA

Floare, M. L., & Allen, S. P. (2020). Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neuroscience Insights, 15. https://doi.org/10.1177/2633105520957302

Vancouver

Floare ML, Allen SP. Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neuroscience Insights. 2020;15. doi:10.1177/2633105520957302

BibTeX
@article{Floare2020,
  author = {Floare, Mara-Luciana and Allen, Scott P},
  title = {Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis},
  journal = {Neuroscience Insights},
  year = {2020},
  volume = {15},
  doi = {10.1177/2633105520957302}
}
Kostenlos starten →